文献速递临床试验与 GCP流行病学与生物统计

冷冻疗法与环形电切术对肯尼亚HIV感染女性高级别宫颈病变复发的影响:一项随机临床试验

Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

在肯尼亚单中心纳入400例HIV感染合并CIN2或3的女性,1:1随机接受冷冻疗法(n=200)或LEEP(n=200),随访24个月。冷冻组60例(30%)复发CIN2及以上,LEEP组37例(19%),相对风险1.71(95%CI 1.12-2.65),风险差7.9%(95%CI 1.9%-14.0%),P=.01。LEEP较冷冻疗法显著降低24个月宫颈肿瘤复发率。

要点

  • HIV感染合并CIN2或3女性中,冷冻疗法组24个月复发CIN2及以上为30%,LEEP组为19%。
  • 冷冻疗法较LEEP的复发相对风险为1.71(95%CI 1.12-2.65),风险差7.9%(95%CI 1.9%-14.0%),P=.01。
  • 冷冻组40例(45起事件)、LEEP组30例(38起事件)发生不良事件。

核心结论

  • 在HIV感染合并CIN2或3的女性中,LEEP较冷冻疗法显著降低24个月宫颈肿瘤复发率。
  • 作者认为需开展成本效果分析以确定LEEP的额外获益是否代表对所需额外资源的有效利用。

研究设计与样本

  • 单中心随机临床试验,2011年6月至2016年9月在肯尼亚纳入HIV感染合并CIN2或3的女性,经巴氏涂片和确诊活检筛查。
  • 400例女性1:1随机接受冷冻疗法(n=200)或LEEP(n=200),每6个月随访一次,共24个月,行巴氏涂片和确诊活检。
  • 末次研究操作实施日期为2016年9月7日;339例(85%)完成试验;中位年龄37.4岁(四分位距31.9-43.8岁)。

主要发现

  • 24个月内,冷冻疗法组60例(30%)复发CIN2及以上,LEEP组37例(19%)。
  • 冷冻疗法较LEEP的相对风险为1.71(95%CI 1.12-2.65),风险差为7.9%(95%CI 1.9%-14.0%),P=.01。
  • 冷冻疗法组40例发生45起不良事件(包括病理改变和其他原因死亡),LEEP组30例发生38起不良事件(包括病理改变和无关妇科并发症)。

局限性

  • 原文为单中心研究。
  • 作者认为需开展成本效果分析以确定LEEP的额外获益是否代表对所需额外资源的有效利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The World Health Organization recommends cryotherapy or loop electrosurgical excision procedure (LEEP) for histologically confirmed cervical intraepithelial neoplasia (CIN) grade 2 or higher regardless of HIV status. Cryotherapy is more feasible in resource-limited settings but may be less effective for women living with HIV. OBJECTIVE: To evaluate whether cryotherapy or LEEP is a more effective treatment for high-grade cervical lesions among women with HIV. DESIGN, SETTING, AND PARTICIPANTS: Single-center randomized trial conducted among women with HIV and CIN grade 2 or 3. From June 2011 to September 2016, women with HIV in Kenya underwent cervical screening with Papanicolaou testing and confirmatory biopsy. The final date on which a study procedure was administered was September 7, 2016. INTERVENTIONS: Women with HIV infection and CIN grade 2 or 3 were randomized 1:1 to receive cryotherapy (n = 200) or LEEP (n = 200) and were followed up every 6 months for 24 months with a Papanicolaou test and confirmatory biopsy. MAIN OUTCOME AND MEASURES: The primary outcome was disease recurrence, defined as CIN grade 2 or higher on cervical biopsy, during the 24-month follow-up period. RESULTS: Among 400 women who were randomized (median age, 37.4 [interquartile range, 31.9-43.8] years), 339 (85%) completed the trial. Over 2 years, 60 women (30%) randomized to cryotherapy had recurrent CIN grade 2 or higher vs 37 (19%) in the LEEP group (relative risk, 1.71 [95% CI, 1.12-2.65]; risk difference, 7.9% [95% CI, 1.9%-14.0%]; P = .01). Adverse events occurred in 40 women (45 events, including change in pathology and death due to other causes) in the cryotherapy group and in 30 women (38 events, including change in pathology and unrelated gynecological complications) in the LEEP group. CONCLUSIONS AND RELEVANCE: In this single-center study of women with HIV infection and CIN grade 2 or 3, treatment with LEEP compared with cryotherapy resulted in a significantly lower rate of cervical neoplasia recurrence over 24 months. Cost-effectiveness analysis is necessary to determine whether the additional benefit of LEEP represents an efficient use of the additional resources that would be required. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01298596.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Greene SA, De Vuyst H, John-Stewart GC, et al. Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial. JAMA. 2019. PMID: 31638680. doi:10.1001/jama.2019.14969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。